Member Profile ohm20 | Latest Posts

Some time ago on the YMB someone sa

06/21/2022 11:14:43 PM

(1)

I wished they had actual numbers ov

06/21/2022 10:32:15 PM

(14)

Inflammation and blood clotting are

06/21/2022 9:10:15 AM

The last things CYDY needs is more

06/21/2022 9:01:29 AM

(14)

would 10% of trial participants sur

06/21/2022 8:58:26 AM

(20)

Patent is assigned to Cytodon. Assi

06/20/2022 7:56:44 AM

So how your hypothesis explain the

06/17/2022 9:53:48 PM

From the looks of it TMP-2 seems to

06/17/2022 9:19:31 PM

How long has it been... since Dr. R

06/17/2022 7:06:03 PM

You and/or your phone used only one

06/17/2022 11:56:07 AM

(16)

There are 4 ligands of the CCR5 rec

06/17/2022 9:31:35 AM

(13)

Telehealth Stock Talk

06/17/2022 6:23:53 AM

If management misses June’s promi

(1)

But what Maddon proposed is the rea

06/17/2022 3:23:26 AM

(15)

but I believe they are seeking an o

06/17/2022 2:55:04 AM

(10)

Given the last conference call it m

06/17/2022 2:33:48 AM

Someone sent the 2nd iteration of t

06/17/2022 2:31:23 AM

did I mistake this for a group of s

06/17/2022 2:27:33 AM

(12)

There should be no need to use Pest

06/17/2022 2:15:06 AM

(5)

Alcoholic liver disease is most com

06/17/2022 1:58:24 AM

The only thing was… it was a smal

06/16/2022 7:29:21 AM

Not sure what was so bad about sub-

06/16/2022 7:23:05 AM

(14)

feur-shitstain's role is to act as

06/16/2022 4:34:03 AM

First on that list should be ohm20.

06/16/2022 4:15:58 AM

I gotta wonder if Brazil was Nader�

06/16/2022 4:12:49 AM

(13)

i think there is a chance that Pest

06/16/2022 4:06:44 AM

The blocking of CCL5 (RANTES) is wh

06/14/2022 11:29:35 AM

Another way that CCR5 induces NASH.

06/14/2022 10:41:44 AM

(15)

last year avisol capital partners p

06/14/2022 12:45:41 AM

(12)

But that doesn't mean all is lost,

06/14/2022 12:11:24 AM

Dr. Ashok Dutta of Avisol relays hi

06/13/2022 11:59:00 PM

(11)

I think it's very relevant, or if n

06/13/2022 4:29:43 PM

Maybe someone is, but I have no ide

06/13/2022 4:41:12 AM

wont leronlimab prove to be as effe

06/13/2022 4:38:50 AM

can’t recall. cT1 or PDFF. One of

06/13/2022 4:30:41 AM

(10)

Overall, it remains poorly defined

06/13/2022 3:46:27 AM

(1)

Would you tend to think that with t

06/13/2022 3:35:22 AM

(4)

The fact that the 700mg dose was so

06/12/2022 1:01:47 PM

(8)

There are around 300,000 HIV patien

06/12/2022 7:27:26 AM

(8)

But craigakess is buying shares*. *

06/11/2022 9:37:20 PM

Those are only the ones that live l

06/11/2022 9:34:55 PM

but they CAN choose to accept stock

06/11/2022 9:26:31 PM

I don’t think with 7 patients in

06/11/2022 9:21:06 PM

I think with NASH a 30% improvement

06/11/2022 9:01:06 PM

(16)

or a rejection from a regulatory ag

06/11/2022 8:14:51 PM

Here's my thought: If CYDY submits

06/11/2022 7:58:59 PM

(11)

An interesting read on NAFLD/NASH.

06/11/2022 2:38:58 AM

(10)

To run it. I'm sure Dr. Recknor alr

06/10/2022 2:08:25 PM

(4)

Whatever timeline the FDA would exp

06/10/2022 1:01:01 PM

In NASH one thing to consider is th

06/10/2022 12:47:10 PM

Until it becomes dead tissue (fully

06/10/2022 9:42:03 AM